Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Cash & Current Investments (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Cash & Current Investments for 10 consecutive years, with $19.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 71.59% to $19.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $19.6 million, a 71.59% decrease, with the full-year FY2025 number at $19.6 million, down 71.59% from a year prior.
  • Cash & Current Investments was $19.6 million for Q4 2025 at Orthopediatrics, up from $18.9 million in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $118.3 million in Q4 2022 to a low of $9.0 million in Q4 2021.
  • A 5-year average of $55.5 million and a median of $52.1 million in 2022 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: plummeted 89.27% in 2021, then skyrocketed 1213.46% in 2022.
  • Orthopediatrics' Cash & Current Investments stood at $9.0 million in 2021, then surged by 1213.46% to $118.3 million in 2022, then crashed by 32.11% to $80.3 million in 2023, then fell by 14.29% to $68.8 million in 2024, then tumbled by 71.59% to $19.6 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Cash & Current Investments are $19.6 million (Q4 2025), $18.9 million (Q3 2025), and $46.6 million (Q2 2025).